Mixtures of veterinary medicinal compounds in manured soils

Similar documents
Are Veterinary Medicines Causing Environmental Risks?

Current EU Antibiotic Maximum Residue Limits

Index. Note: Page numbers of article titles are in boldface type.

Amoxicillin trihydrate and potassium clavulanate. Amoxicillin trihydrate and potassium clavulanate. Amoxicillin trihydrate and potassium clavulanate

Deborah A. Cera - Division of Compliance Center for Veterinary Medicine, FDA

European Public MRL assessment report (EPMAR)

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Drug Use on the Farm & Antibiotic Resistance in Raw, Stored, & Treated Manures

Revolutionary Milk Analysis

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Avoiding residues and an FDA Inspection

Methods development to detect antibiotic activity in water samples

Guidance for completing the OIE template for the collection of data on antimicrobial agents intended for use in animals

Risk-Based Approach to Developing the National Residue Sampling Plan

Premi Test. Art. No. R3900. R-Biopharm AG. Fast Determination of antibiotic residues in less than 4 hours

European public MRL assessment report (EPMAR)

Fate and Transport of Hormones & Antimicrobials

Unique, fast-acting, and long-lasting injectables for livestock health & nutrition

20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 20mL, 50mL, 100mL. 50mL, 100mL. 50mL, 100mL.

Agriculture & Agri-Food Canada, Research Centre, Lethbridge, AB. Environment Canada, Saskatoon, Saskatchewan

Residues. Mike Apley, DVM, PhD

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Web Based Sales Data and Animal Population Data Collection Protocol (version 2)

EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment

Result of the OIE data collection

Analysis of Hormones & Anabolics

Key Lecture: Entry, occurrence, behavior and effects of pharmaceuticals in the environment

Multi-residue Method II for Veterinary Drugs by HPLC (Animal and Fishery Products)

N.C. A and T List of Approved Analgesics 1 of 5

One Analysis, One Column, Less than 9 Minutes for Over 60 Multiclass Antibiotics

COUNTRY PRESENTATION ON RECENT ACTIVITIES CARRIED OUT BY FOCAL POINT BHUTAN

Strength Animal species Recommended dose. Member State Applicant Invented name Pharmaceutical form

Monitoring of Antibiotic Residues in Milk Development of the New Biosensor System MCR 3 for Routine Practical Analyses

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

Knowledge list Avian/Exotic Pharmacology and Commonly Used Drugs

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

Country Report: Malaysia

Summary of Product Characteristics

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France Volumes and estimated exposure of animals to antimicrobials

Antibiotic Residues in Animal Waste: Occurrence and Degradation in Conventional Agricultural Waste Management Practices

Metacam 1.5 mg/ml oral suspension for dogs

Scientific Discussion post-authorisation update for Rheumocam extension X/007

crippling production of the bacterial cell wall that protects the cell from the external environment PS

The epidemiology of antimicrobial resistance and the link between human and veterinary medicine

SUMMARY OF PRODUCT CHARACTERISTICS

The use of antimicrobials in livestock production and antimicrobial resistance in pathogens from livestock

Antibiotic Sales and Use Overview Prepared for Approvals and ACVM Group. ISBN No: (online)

No July 2000 REGULATION. respecting veterinarians authorisations to prescribe drugs SECTION II

Introduction to Pharmacokinetics and Pharmacodynamics

UBA and Tukes concerned about the environmental impacts of veterinary medicines

Pesticide and antibiotic pollution in the Mekong Delta

Antibiotics use and Considerations: Calves and Heifers CLASSIFICATION OF CALVES. Danielle A. Mzyk TITLE 24 PT. ARIAL BOLD ALL CAPS

Commonly Used Analgesics

DRUG REGULATIONS & WITHDRAWAL TIMES

CLINICAL MASTITIS PERCEPTIONS OF KANSAS DAIRY PRODUCERS. J.R. Roberson 1

General Directorate of Animal Health and EpizooticDiseases Control. Dr.Sabah Hassan Abdelgadir Sudan Focal Point for Veterinary products

Occurrence and transformation of veterinary pharmaceuticals and biocides in manure: a literature review

Objectives. Antibiotics uses in food animals 3/25/2018. California Dairy Productions. Antimicrobial Resistance in the Animal Production Environment

Poultry Science Journal ISSN: (Print), (Online)

Why? The dairy industry is now under increased drug residue surveillance. Meat and Milk Drug Residues: Current Dairy Industry Topics

CONCORD DRUGS LIMITED Hyderabad

Refusal EPAR for Naxcel

Using Charm II 7600 For Residue Testing in Meats in Barbados

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

Milk and Dairy Beef Residues: Incidence & Communications. Dairy Response Planning Betsy Flores, Nat l Milk Producers Federation April 16, 2013

Quantification of EPA 1694 Pharmaceuticals and Personal Care Products in Water at the ng/l Level Utilizing Online Sample Preparation with LC-MS/MS

Agricultural Research Division, American Cyanamid Company, Princeton, NJ 08540

Overview of Antibiotics in China Animal Industry. Rongsheng Qiu on Invitation of PHILEO ROME SEMINAR 2017

Summary of Product Characteristics

Sales survey of Veterinary Medicinal Products containing Antimicrobials in France

Pain Management in Racing Greyhounds

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SELECT NEWS. Florfenicol Monograph: Injectable & Oral Therapy for Swine

Country Report Myanmar

SUMMARY OF PRODUCT CHARACTERISTICS

Extraction and Cleanup Protocols for LC-MS/MS Multiresidue Determination of Veterinary Drugs in Tissue and Milk Samples

SUMMARY OF PRODUCT CHARACTERISTICS. Animeloxan 1.5 mg/ml oral suspension for dogs. Active substance: Meloxicam 1.5 mg (equivalent to 0.

SUMMARY OF PRODUCT CHARACTERISTICS

AMR dissemination in the environment Professor Liz Wellington

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

DR. BASHIRU BOI KIKIMOTO

Draft agreed by the Environmental Risk Assessment Working Party (ERAWP) 30 April 2018

Antimicrobial use in animals: OIE collection of data on antimicrobial agents used in animals (2015)

Medically Important Antibiotics in Animal Agriculture

CAT LITTER and DOG FECES: COMPOST or WASTE?

Veterinary Feed Directive Information

Inflammatory pain in cattle

Beef Producers. The Judicious Use of Antimicrobials for

ManureTracker: On the Trail of Hormones, Antimicrobials and Antimicrobial Resistance Genes

Veterinary Feed Directive: What You Need to Know

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Herbal Medicine for Animal Use in JAPAN

Antimicrobial use and Antimicrobial resistance: chapter 6.7 and 6.8 of the OIE Terrestrial Animal Health

AMU/AMR Policy for animals in Korea Jaehong CHANG, DVM, MS

European public MRL assessment report (EPMAR)

Changes in Antibiotic Labeling Veterinary Feed Directive

Environmental impacts of Veterinary Medicines - State of knowledge, options for improvement

Veterinary Feed Directive

Transcription:

Workshop Pharmaceuticals in Soil, Sludge and Slurry Mixtures of veterinary medicinal compounds in manured soils Nadine Tauchnitz Daniela Gildemeister, Silvia Berkner Dessau-Roßlau, 18th June to 19th June 2013

Input of veterinary pharmaceuticals into soil Application of pharmaceuticals animals at pasture livestock farms Excretion urine, faeces Storage liquid (slurry) or solid manure (dung) Photochemical degradation Pasture land Transfer into plants Fertilisation Field Chemical and microbial degradation Run-off Leaching Surface water Groundwater Drinking water Mineralisation Accumulation (modified after Stroh, 2005; Stevens, 2009) -1- Background

Input of veterinary pharmaceuticals into soil kind and amount of pharmaceuticals animal metabolism kind and amount of fertilisers matrix properties of fertilisers storage of fertilisers application techniques application times soil tillage system/incorporation of fertilisers Transfer into plants Chemical and microbial degradation metabolites Mineralisation Accumulation Run-off Leaching Surface water Groundwater Drinking water Physicochemical properties of pharmaceuticals degradability adsorption capacity (K d ) lipophilicity (K ow, K oc ) polarity and others Soil properties mineral content and composition content of organic matter ionic strength ph-value temperature and others -2- Background

Veterinary pharmaceuticals in environmental samples Antibiotics tetracyclines (chlortetracycline) sulfonamides (sulfadiazine) trimethoprim fluoroquinolones (enrofloxacin) macrolides (tylosin) Antiparasitics benzimidazoles (flubendazol) avermectines (ivermectin) Organic fertiliser Soil Antibiotics tetracyclines (chlortetracycline) sulfonamides (sulfadimidin) Antiparasitics benzimidazoles (flubendazol) Surface water Groundwater Antibiotics tetracyclines (chlortetracycline) sulfonamides (sulfadimidin) trimethoprim fluoroquinolones (enrofloxacin) macrolides (tylosin) Antiparasitics benzimidazoles (flubendazol) avermectines (ivermectin) -3- Background

Mixtures of veterinary pharmaceuticals Parent substances + metabolites = Mixture of multicomponents interactions o synergistic o additive o antagonistic Increase or decrease of the mixtures toxicity compared to single substances Underestimation of the environmental risk Requirement of the predicted environmental concentration (PEC soil ) to assess mixtures toxicity EMA guideline on pharmaceutical fixed combination products: Consideration of separate active substances (single substances) as basis for data on fixed combination products EMA: European Medicines Agency PEC soil(mix) : addition of PEC soil of all single substances in the mixture -4- Background

Difficulties in the assessment of environmental risk of veterinary pharmaceuticals mixtures: no central registration of the consumption of veterinary pharmaceuticals limitation of analytical methods for the quantification of pharmaceutical residues in soils (non-extractable residues, sequestration) Aim of the present study: Estimation of the exposure of veterinary pharmaceutical mixtures by anonymous questionnaire surveys of farmers Main objectives: o quantification of the amount of applied veterinary pharmaceutical agents per farm for the slurry storage period o calculation of the expected active agent concentration of pharmaceuticals in slurry (worst case, without metabolism in animals) o exposure assessment of pharmaceutical agents by calculation of predicted environmental concentration in soil (PEC soil ) -5- Objectives

Methods o anonymous questionnaire surveys of farmers o duplicates of the regular forms on drug application to agricultural animals for one year ( 57 AMG, German Drug Law, documentation requirement) o calculation of the expected agents concentration in slurry without metabolism in animals PEC slurry = agents in slurry storage time/applied slurry amount o calculation of the predicted environmental concentration in soil (PEC soil ) in µg/kg according to the EMA guidelines 1 PEC soil = N max * PEC slurry N slurry * soil depth * bulk density N max : N slurry : Soil depth: 170 kg N/ha (max. N application according to fertiliser ordinance DüV) 5,3 kg/m³ (N content slurry pig fattening), 3,8 kg/m³ (N content slurry dairy farming) 0,05 bzw. 0,2 m, Bulk density: 1500 kg/m³ 1 EMEA (European Medicines Agency), CVMP (Committee for Medicinal Products for Veterinary Use). Revised Guideline on Environmental Impact Assessment for Veterinary Medicinal Products. In Support of the VICH-Guidelines GL 6 and GL 38. EMEA/CVMP/ERA/418282/2005-Rev. 1. (2008). -6- Methods

Example - duplicates of the regular forms on drug application to animals -7- Methods

Example - excel sheet for data evaluation Time period 01.01.-31.12.2010 Columns A B C D E F G H I J K L M N O P Q R S identification classification agent amount amount C w1 C w2 C w3 C w1 C w2 C w3 animals C Gw1 C Gw2 C Gw3 date applicationanimals duration ml g mg/ml* mg/ml mg/ml mg mg mg amount mg mg mg category days mg/kg mg/kg mg/kg Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 10 3000 25.12.2010 i.m. F 5 Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 20 30000 10.12.2010 i.m. F 5 Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 20 6000 17.10.2010 i.m. F 5 Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 20 6000 16.09.2010 i.m. F 4 Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 20 6000 14.09.2010 i.m. F 4 Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 20 6000 09.09.2010 i.m. F 4 Amoxycilllin ß-Lactam Amoxycilllin 2 150 300 10 18000 18.08.2010 i.m. F 6 Baycox (5 %) Kokzidienmittel Toltrazurilum 1 50 50 250 12500 17.12.2010 oral F 2 Baycox (5 %) Kokzidienmittel Toltrazurilum 1 50 50 250 12500 25.11.2010 oral F 2 Baycox (5 %) Kokzidienmittel Toltrazurilum 1 50 50 250 12500 05.11.2010 oral F 2 Baycox (5 %) Kokzidienmittel Toltrazurilum 1 50 50 250 12500 23.09.2010 oral F 2 Baycox (5 %) Kokzidienmittel Toltrazurilum 1 50 50 250 12500 02.09.2010 oral F 2 Bisolvon Bronchosekretolytika Bromhexinhydrochlorid 10 3 30 2 60 25.12.2010 oral MS 5 Bisolvon Bronchosekretolytika Bromhexinhydrochlorid 10 3 30 20 4200 26.05.2010 oral JS 5 Cobactan (2,5 %) ß-Lactam Cefquinonum 2 25 50 25 1250 22.07.2010 i.m. F 2 Cobactan (2,5 %) ß-Lactam Cefquinonum 2 25 50 25 1250 10.02.2010 i.m. F 2 Synutrim Sulfonamid SDZ, Trim. 0,32 600 120 192 38,4 450 6E+05 120960 29.12.2010 oral F 7 Synutrim Sulfonamid SDZ, Trim. 0,65 600 120 390 78 440 1E+06 240240 21.12.2010 oral F 7 Synutrim Sulfonamid SDZ, Trim. 0,712 600 120 427,2 85,44 800 2E+06 478464 15.12.2010 oral F 7 Synutrim Sulfonamid SDZ, Trim. 0,63 600 120 378 75,6 450 1E+06 238140 02.12.2010 oral F 7 Synutrim Sulfonamid SDZ, Trim. 0,63 600 120 378 75,6 450 1E+06 238140 10.12.2010 oral F 7 Marbocyl 10 % Fluorquinolon Marbofloxacinum 5 100 500 20 10000 29.12.2010 i.m. MS 2 Marbocyl 10 % Fluorquinolon Marbofloxacinum 5 100 500 6 6000 17.12.2010 i.m. MS 2 Marbocyl 10 % Fluorquinolon Marbofloxacinum 5 100 500 20 10000 25.11.2010 i.m. MS 2 Marbocyl 10 % Fluorquinolon Marbofloxacinum 5 100 500 10 5000 06.11.2010 i.m. MS 2 Marbocyl 10 % Fluorquinolon Marbofloxacinum 5 100 500 20 10000 24.09.2010 i.m. MS 2 Powerflox Fluorquinolon Enrofloxacin 2 100 200 16 3200 29.10.2010 i.m. F 3 Powerflox Fluorquinolon Enrofloxacin 2 100 200 16 3200 10.04.2010 i.m. F 3 Powerflox Fluorquinolon Enrofloxacin 2 100 200 16 3200 03.03.2010 i.m. F 3 = D (E)*F = D (E)*G = I (J)*L*S -7- Methods

distribution of alltogether 30 questionnaires reply of 10 5 of them were fattening usable farm for the (1173 assessment animals) production targets: dairy cows, fattening pigs Application of veterinary pharmaceuticals in a pig 0.3% 1.6% 0.04% antibiotics hormones antiparasitics antiphlogistics analgetics bronchosecretogogues 97.9% -8- Results

Application of antibiotic agents in a pig fattening farm (1173 animals) 3.3% 4.1% 21.7% 0.3% 70.7% 0.02% beta-lactams fluoroquinolones sulfonamides/trimethoprim tetracyclines aminoglycosides polypeptides -9- Results

Application of veterinary pharmaceuticals in a dairy farm (750 animals) 0.01% 98.8% 0.68% 0.53% antibiotics hormones antiphlogistics analgetics bronchosecretogogues sedatives -10- Results

Application of antibiotic agents in a dairy farm (750 animals) 17.4% 0.6% 6% 0.3% 0.7% 74.9% beta-lactams tetracyclines fluoroquinolones aminoglycosides amphenicoles macrolides -11- Results

Amount of consumed pharmaceuticals (kg) Annual course of the administered veterinary pharmaceuticals (pig fattening farm) 20 18 16 14 12 10 8 6 4 2 0 bronchosecretogogues antiparasitics hormones analgetics antiphlogistics antibiotics -12- Results

Annual course of the administered antibiotics (pig fattening farm) 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% beta-lactams aminoglycosides sulfonamides/trimethoprim fluoroquinolones tetracyclines polypeptides -13- Results

Predicted Environmental Concentration in slurry and soil (pig fattening farm) PEC slurry PEC slurry PEC slurry PEC soil (5cm depth) PEC soil (20 cm depth) [µg L -1 ] [µg L -1 ] [µg L -1 ] [µg kg -1 ] [µg kg -1 ] April August average antibiotics beta-lactams 350.76 431.67 391.21 16.73 4.18 fluoroquinolones 79.64 79.73 79.69 3.41 0.85 aminoglycosides 4.44 3.33 3.89 0.17 0.04 tetracyclines 1780.60 13758.27 7769.44 332.28 83.07 sulfonamides 8490.72 19076.06 13783.39 589.48 147.37 trimethoprim 1698.14 3815.21 2756.68 117.90 29.47 polypeptides 637.37 911.52 774.45 33.12 8.28 hormones oxytocin 0.01 0.01 0.01 0.00 0.00 progestagens 7.04 6.86 6.95 0.30 0.07 gonadotropin 0.03 0.04 0.04 0.00 0.00 prostaglandin agonists 3.36 3.05 3.21 0.14 0.03 antiphlogistics excretion flunixin 188.47 3.33 95.90 4.10 metabolism 1.03 meloxicam 8.47 4.66 6.57 0.28 degradation 0.07 dexamethasone 0.00 0.09 0.05 0.00 0.00 antiparasitics ivermectin 15.36 18.13 16.75 0.72 0.18 toltrazurilum 33.33 51.81 42.57 1.82 0.46 analgetics test organisms metamizole 0.28 0.32 0.30 0.01 0.00 bronchosecretogogues bromhexine hydrochloride 0.00 2.80 1.40 0.06 0.01 PEC Mix 1100.51 275.13 > triggervalue 100 µg/kg Environmental risk assessment has to proceed to phase II physical-chemical properties environmental behaviour effects on different aquatic and terestrial -14 - Results

Predicted Environmental Concentration in slurry and soil (dairy farm) PEC slurry PEC slurry PEC slurry PEC slurry PEC soil (5cm depth) PEC soil (20 cm depth) [µg L -1 ] [µg L -1 ] [µg L -1 ] [µg L -1 ] [µg kg -1 ] [µg kg -1 ] May July Oct. average antibiotics beta-lactams 299.32 467.10 346.21 370.88 22.12 5.53 fluoroquinolones 3.84 41.53 46.42 30.59 1.82 0.46 aminoglycosides 0.00 0.44 3.42 1.29 0.08 0.02 tetracyclines 0.00 104.21 113.01 72.41 4.32 1.08 amphenicoles 1.04 0.00 3.92 1.65 0.10 0.02 macrolides 0.00 0.00 14.74 4.91 0.29 0.07 hormones gonadotropin 0.00 0.00 0.00 0.00 0.00 0.00 prostaglandin agonists 0.00 0.00 0.07 0.02 0.00 0.00 antiphlogistics dexamethasone 0.00 0.06 0.19 0.08 0.00 0.00 flunixin 0.00 0.13 9.16 3.09 0.18 0.05 carprofen 0.00 0.00 0.15 0.05 0.00 0.00 meloxicam 0.00 0.00 0.12 0.04 0.00 0.00 analgetics metamizole 0.00 0.00 0.00 0.00 0.00 0.00 PEC Mix 28.93 7.23 no environmental risk -15 - Results

Maximum of 42 chemical substances Overview of administered chemical substances chemical substance substance classes therapeutic classes Amoxicillin beta-lactams antibiotics Ampicillin beta-lactams antibiotics Oxacillin beta-lactams antibiotics Penicillin beta-lactams antibiotics Procain-Penicillin beta-lactams antibiotics Benzathin-Benzylpenicillin beta-lactams antibiotics Benzylpenicillin Procain beta-lactams antibiotics Dihydrostreptomycinsulfat beta-lactams antibiotics Benzylpenicillin-Kalium beta-lactams antibiotics Neomycin beta-lactams antibiotics Cefaperazon beta-lactams antibiotics Cefapirin beta-lactams antibiotics Cefquinonum beta-lactams antibiotics Ceftiofurum beta-lactams antibiotics Ceftiofur-Natrium beta-lactams antibiotics Cloxacillin beta-lactams antibiotics Cloxacillin-Natrium beta-lactams antibiotics Cloxacillin-Benzathin beta-lactams antibiotics Oxytetracyclin tetracyclines antibiotics Tylosin macrolides antibiotics Danofloxacin fluoroquinolones antibiotics Enrofloxacin fluoroquinolones antibiotics Gentamycin aminoglycosides antibiotics Lincomycin aminoglycosides antibiotics Neomycin aminoglycosides antibiotics Streptomycin aminoglycosides antibiotics Dihydrostreptomycin aminoglycosides antibiotics Cloprostenol prostaglandin agonists hormones Trometamolum prostaglandin agonists hormones Butylscolopamin parasympathicolytic antispasmodics Buserelin peptide hormones Flunixin non-steroidal anti inflammatory drugs antiphlogistics Carprofen non-steroidal anti inflammatory drugs antiphlogistics Meloxicam non-steroidal anti inflammatory drugs antiphlogistics Dexamethason glucocorticosteroids antiphlogistics Diazepam benzodiazepine sedatives Xylazinhydrochlorid thiazine amines sedatives Embutramid hydroxybutyrate narcotics Florfenicol amphenicoles antibiotics Ketoprofen non-steroidal anti inflammatory drugs analgetics Metamizol non-opioid analgesics analgetics Methylsalicylat non-opioid analgesics analgetics -16 - Results

application of maximal 42 different chemical substances and 16 different substance classes in farms surveyed (primarily antibiotics: 82 to 100 %) markedly higher consumption of veterinary drugs in pig fattening compared to dairy farming pig fattening farms mainly used not easily degradable, environmentally relevant antibiotics (tetracyclines, sulfonamides/trimethoprim) with PEC soil markedly exceeding trigger value of 100 µg/kg for pig slurry calculation of PEC soil(mix) higher than1000 µg/kg and furthermore application of substance classes which was already found in environmental samples suggests: a high probability that mixtures of different veterinary drug components may occur in manured soils requirement of continued, more representative data collection (central digital registration of drug application) -17- Summary

Thanks for your attention!